{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T10:22:29Z","timestamp":1787653349290,"version":"build-2736575974"},"reference-count":48,"publisher":"Informa UK Limited","issue":"19","license":[{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"funder":[{"DOI":"10.13039\/100004331","name":"Johnson & Johnson","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004331","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Future Oncology"],"published-print":{"date-parts":[[2026,8,9]]},"DOI":"10.1080\/14796694.2026.2710562","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T16:31:07Z","timestamp":1785861067000},"page":"2299-2311","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Smoldering multiple myeloma: a multi-country mixed-methods study on disease perceptions and patient treatment preferences"],"prefix":"10.1080","volume":"22","author":[{"given":"Matthew","family":"Quaife","sequence":"first","affiliation":[{"name":"Evidera","place":["London, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Jimenez-Moreno","sequence":"additional","affiliation":[{"name":"Evidera","place":["London, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blanca","family":"Gros Otero","sequence":"additional","affiliation":[{"name":"Johnson & Johnson","place":["Madrid, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aisha","family":"Asra","sequence":"additional","affiliation":[{"name":"Johnson & Johnson","place":["London, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niodita","family":"Gupta-Werner","sequence":"additional","affiliation":[{"name":"Johnson & Johnson","place":["Horsham, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharine S.","family":"Gries","sequence":"additional","affiliation":[{"name":"Johnson & Johnson","place":["Raritan, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Kristin","family":"Leisten","sequence":"additional","affiliation":[{"name":"Johnson & Johnson","place":["Neuss, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Matt","sequence":"additional","affiliation":[{"name":"Johnson & Johnson","place":["Raritan, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Carson","sequence":"additional","affiliation":[{"name":"Johnson & Johnson","place":["Spring House, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robyn","family":"Dennis","sequence":"additional","affiliation":[{"name":"Johnson & Johnson","place":["Raritan, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianming","family":"He","sequence":"additional","affiliation":[{"name":"Johnson & Johnson","place":["Raritan, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bennett","family":"Levitan","sequence":"additional","affiliation":[{"name":"Johnson & Johnson","place":["Titusville, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sacheeta","family":"Bathija","sequence":"additional","affiliation":[{"name":"Johnson & Johnson","place":["Raritan, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,8,4]]},"reference":[{"key":"e_1_3_8_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-022-00719-0"},{"key":"e_1_3_8_4_1","doi-asserted-by":"publisher","DOI":"10.2147\/BLCTT.S136447"},{"key":"e_1_3_8_5_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1310911"},{"key":"e_1_3_8_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2016.100"},{"key":"e_1_3_8_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-02183-6"},{"key":"e_1_3_8_8_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-209251"},{"key":"e_1_3_8_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-020-00366-3"},{"key":"e_1_3_8_10_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa070389"},{"key":"e_1_3_8_11_1","doi-asserted-by":"publisher","DOI":"10.1182\/hematology.2022000355"},{"key":"e_1_3_8_12_1","unstructured":"Referenced with permission from the NCCN clinical practice guidelines in oncology (NCCN guidelines\u00ae) for multiple myeloma V.2.2026. \u00a9 National Comprehensive Cancer Network Inc; 2026 [cited 2025 Jul 16]. All rights reserved. To view the most recent and complete version of the guideline go online to NCCN.org. NCCN makes no warranties of any kind whatsoever regarding their content use or application and disclaims any responsibility for their application or use in any way."},{"key":"e_1_3_8_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-020-0718-z"},{"key":"e_1_3_8_14_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2021.3971"},{"key":"e_1_3_8_15_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.01740"},{"key":"e_1_3_8_16_1","unstructured":"Johnson & Johnson. European Commission approves DARZALEX\u00ae (daratumumab) as the first licensed treatment for patients with high-risk smouldering multiple myeloma [press release]. Beerse Belgium: jnj.com; 2025 [cited 2025 Jul 25]. Available from: https:\/\/www.jnj.com\/media-center\/press-releases\/european-commission-approves-darzalex-daratumumab-as-the-first-licensed-treatment-for-patients-with-high-risk-smouldering-multiple-myeloma#:~:text=BEERSE%2C%20BELGIUM%20(23%20July%202025 patients%20with%20smouldering%20multiple%20myeloma%20("},{"key":"e_1_3_8_17_1","unstructured":"ClinicalTrials.gov. Search results for: smoldering multiple myeloma | Not yet recruiting recruiting active not recruiting studies | Interventional studies [internet]. Bethesda (MD): National Library of Medicine; 2025 [cited 2025 Mar 25]. Available from: https:\/\/clinicaltrials.gov\/search?cond=smoldering%20multiple%20myeloma&aggFilters=status:rec%20act studyType:int"},{"key":"e_1_3_8_18_1","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.S259612"},{"key":"e_1_3_8_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40271-021-00501-7"},{"key":"e_1_3_8_20_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.686165"},{"key":"e_1_3_8_21_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1027353"},{"key":"e_1_3_8_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2023.01.016"},{"key":"e_1_3_8_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgo.2024.101781"},{"key":"e_1_3_8_24_1","doi-asserted-by":"publisher","DOI":"10.1080\/14796694.2025.2461430"},{"key":"e_1_3_8_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-024-01161-0"},{"key":"e_1_3_8_26_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-201747"},{"key":"e_1_3_8_27_1","doi-asserted-by":"publisher","DOI":"10.46989\/001c.123608"},{"key":"e_1_3_8_28_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2012-001570"},{"key":"e_1_3_8_29_1","unstructured":"International Conference on Harmonisation. E2D Post-approval safety data management: definitions and standards for expedited reporting [internet]. ICH.org; 2003 [cited 2025 Mar 25]. Available from: https:\/\/database.ich.org\/sites\/default\/files\/E2D_Guideline.pdf"},{"key":"e_1_3_8_30_1","unstructured":"The International Society for Pharmacoeconomics and Outcomes Research. Professional Society for health economics and outcomes research. Good practices reports & more [internet]. ISPOR.org; 2018 [cited 2025 Mar 25]. Available from: https:\/\/www.ispor.org\/heor-resources\/good-practices"},{"key":"e_1_3_8_31_1","unstructured":"European Medicines Agency and Heads of Medicines Agencies. Guideline on good pharmacovigilance practices (GVP). Module VI \u2013 collection management and submission of reports of suspected adverse reactions to medicinal products (Rev 2) [internet]. EMA\/HMA; 2017 [cited 2025 Mar 25]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/regulatory-procedural-guideline\/guideline-good-pharmacovigilance-practices-gvp-module-vi-collection-management-and-submission-reports-suspected-adverse-reactions-medicinal-products-rev-2_en.pdf"},{"key":"#cr-split#-e_1_3_8_32_1.1","unstructured":"European Union. Commission implementing regulation (EU) No 520\/2012 of 19 June 2012 on the performance of pharmacovigilance activities provided for in regulation (EC) no 726\/2004 of the European Parliament and of the council and directive 2001\/83\/EC of the European Parliament and of the council (text with EEA relevance) [Internet]. Official Journal of the European Union"},{"key":"#cr-split#-e_1_3_8_32_1.2","unstructured":"2012 [cited 2025 Mar 25]. Available from: https:\/\/eur-lex.europa.eu\/eli\/reg_impl\/2012\/520\/oj"},{"key":"e_1_3_8_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2010.11.013"},{"key":"e_1_3_8_34_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-021376"},{"key":"e_1_3_8_35_1","doi-asserted-by":"publisher","DOI":"10.1186\/s41687-020-00253-2"},{"key":"e_1_3_8_36_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2021-149827"},{"key":"e_1_3_8_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)70442-5"},{"key":"e_1_3_8_38_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-018-0077-4"},{"key":"e_1_3_8_39_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.624661"},{"key":"e_1_3_8_40_1","doi-asserted-by":"publisher","DOI":"10.1177\/1525822x05279903"},{"key":"e_1_3_8_41_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-024-00980-5"},{"key":"e_1_3_8_42_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-55308-5"},{"key":"e_1_3_8_43_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2409029"},{"key":"e_1_3_8_44_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-209726"},{"key":"e_1_3_8_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(22)00386-6"},{"key":"e_1_3_8_46_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10198-018-0954-6"},{"key":"e_1_3_8_47_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12911-020-01142-w"},{"key":"e_1_3_8_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2018.09.015"},{"key":"e_1_3_8_49_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.01009"}],"container-title":["Future Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14796694.2026.2710562","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/14796694.2026.2710562","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14796694.2026.2710562","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T09:51:56Z","timestamp":1787651516000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14796694.2026.2710562"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,4]]},"references-count":48,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2026,8,9]]}},"alternative-id":["10.1080\/14796694.2026.2710562"],"URL":"https:\/\/doi.org\/10.1080\/14796694.2026.2710562","relation":{},"ISSN":["1479-6694","1744-8301"],"issn-type":[{"value":"1479-6694","type":"print"},{"value":"1744-8301","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,4]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-01-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-24","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-04","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}